Timely HIV Diagnosis and HIV/TB Comanagement Among California Patients
in 2008.
Kong D, Watt JP, Marks SM, Flood JM.
Public Health Rep.
2014 Mar;129(2):170-7
Abstract
HIV Testing in US Tuberculosis Care Settings: A Survey of Current
Practice and Perceived Barriers.
Naureckas C, Carter EJ, Gardner A.
J Public Health Manag Pract.
2013 Dec 10
Abstract
HIV Testing of Tuberculosis Patients by Public and
Private Providers in New York City.
Klein PW, Harris TG, Leone PA, Pettifor AE.
J Community Health. 2013 Oct
31.
Abstract
Impact of HIV on clinical presentation and outcomes of tuberculosis
treatment at primary care level [Short communication].
Henegar C, Behets F, Vanden Driessche K, et al
Int J Tuberc Lung Dis.
2013 Nov;17(11):1411-3
Abstract
Advanced HIV-Infected Adults Initiating ART with Active
Tuberculosis.
Ravimohan S, Tamuhla N, Steenhoff AP, et al
J Infect Dis. 2013 Aug 1
Abstract
Rifampin mono-resistant tuberculosis and HIV co-morbidity in
California, 1993-2008: A Retrospective Cohort Study.
Prach LM, Pascopella L, Barry PM, et al
|
AIDS. 2013 Jul 9.
Abstract
FULL-TEXT ARTICLE
Survival
among Patients with HIV Infection and Smear-Negative Pulmonary
Tuberculosis - United States, 1993-2006.
Cavanaugh JS, Shah NS, Cain KP, Winston CA.
PLoS One.
2012;7(10):e47855.
Paper |
Risk factors for tuberculin skin test conversion among
HIV-infected patients in New York City.
Doshi S, Chen TF, Zapata J,
et
al
Int J Infect Dis. 2012 Apr 26.
Abstract
Risk Factors for Tuberculosis After Highly Active Antiretroviral Therapy
Initiation in the United States and Canada:
Implications for Tuberculosis Screening.
Sterling TR, Lau B, Zhang J, et al
J Infect Dis. 2011
Sep;204(6):893-901.
Abstract
Chronic lung disease and HIV infection are risk factors for
recurrent tuberculosis in a low-incidence setting.
Pettit AC, Kaltenbach LA, Maruri F,
et al
Int Tuberc Lung Dis.
2011 Jul;15(7):906-11.
Abstract
Disseminated tuberculosis in human immunodeficiency virus infection:
ineffective immunity, polyclonal disease
and high mortality.
von Reyn CF, Kimambo S, Mtei L,
et
al
Int J Tuberc Lung Dis. 2011 Aug;15(8):1087-92.
Abstract
Tuberculosis Risk Before and After Highly Active Antiretroviral Therapy
Initiation:
Does HAART Increase the Short-term TB Risk in a Low Incidence TB Setting?
Pettit AC, Jenkins CA, Stinnette SE, et al
J Acquir Immune Defic Syndr. 2011 Mar 17.
Abstract
Achieving international targets for tuberculosis treatment
success among
HIV-positive patients in New York City.
King L, Munsiff SS, Ahuja SD.
Int J Tuberc Lung Dis.
2010 Dec;14(12):1613-1620
Abstract |